BERKSHIRE HATHAWAY INC

BRK-A
About the company

Berkshire Hathaway Inc., together with its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses.

Country: United StatesPrice: $889794.00Market Cap: $1.26T

Investment snapshot

6%positive consensus
Scored 1d ago

Positive

1

BUY / PASS

Neutral / negative

3 / 12

NEUTRAL / FAIL

Median fair value

$602934.21

-32.2% vs price

Models with upside

2 / 16

Positive margin of safety

Key risk

All 4 investors flag BRK-A's efficiency

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILPASSFAILFAILFAILFAILFAILFAILFAILNEUTRALNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/A
Margin of Safety-23.1%+22.7%-62.1%N/A-1.8%-243.1%-114.0%+20.8%-74.5%-276.3%-35.5%N/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-09

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-02

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-09

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-02

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-09

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-02

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-02

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30

Latest source filing: 2026-11-09

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-02

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-09

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-03-02

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-02

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-09

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-09

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-02

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-09

Score computed: 2026-11-14

Where It Passes

    Where It Falls Short

    • Efficiency0% pass✗ 5▾

      All 4 investors flag BRK-A's efficiency

      Revenue / Total Assets Change YoY0.32x -> 0.30x
      ✗PiotroskiImproved YoY
      Return on Invested Capital
      ✗Munger> 15%
      ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable
      ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
      Reinvestment Rate x ROIC
      ✗AkreReinvestment Rate * ROIC > 10%
      ROIC (5-year)
      ✗SleepROIC > 12% in a majority of years
    • Valuation8% pass✓ 4✗ 22▾

      11 of 12 flag BRK-A's valuation — Graham, Lynch, Dreman +8 more

      Net income / market capitalization+6.12%; #1390/6340 (top 21.9%)
      ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
      Price / 3-yr avg EPS15.3x
      ✗Graham<= 15x
      Price-to-Book Ratio1.8x
      ✗Graham<= 1.5x
      P/E x P/B27.20
      ✗Graham<= 22.5
      Basic earnings-growth PEG (dividends excluded)1.62
      ✗Lynch< 1.0 (ideally < 0.5)
      Price / EPS19.1x
      ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
      Price / (CFO / Shares)27.8x
      ✗Dreman< 8x
      Price / Book Value per Share1.8x
      ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
      Valuation ReasonablenessP/E=19.1x, OE Yield=4.7%
      ✓MungerP/E < 25 or Owner Earnings Yield > 5%
      P/E or FCF YieldP/E=19.1x, FCF Yield=2.0%
      ✗PabraiP/E < 15 or FCF Yield > 10%
      P/B or P/E vs. Historical AverageP/E=19.1x, P/B=1.8x
      ✓MarksP/E < 15 or P/B < 2.0
      Discount to Intrinsic Value-1.8% (IV=$874375.00 vs Price=$889794.00)
      ✗Marks>= 20% below intrinsic value
      Price / FCF per Share51.1x
      ✗Ackman<= 25
      Price vs. Trailing Low127% of trailing low ($702614.00)
      ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
      Positive book equity / market capitalization+0.6041; #2512/6449 (top 39.0%)
      ✗AsnessTop 30% of eligible cross-section
      Price / Diluted EPS19.1x
      ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
      (EPS CAGR % + Dividend Yield %) / P/E
      ✗Neff> 0.7 (Neff's published traditional edge)
      Price / Tangible Book Value per Share2.02x
      ✗SchlossP/TBV <= 1.00x (app cutoff)
      Book Value per Share Change+82.1%
      ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
      Revenue / market capitalization+0.3137; #3264/5247 (top 62.2%)
      ✗OshaughnessyTop 10% of eligible cross-section
      (Operating cash flow - capex) / market capitalization+1.81%; #2281/4519 (top 50.5%)
      ✗OshaughnessyTop 10% of eligible cross-section
      Trailing six-month price return through the evaluation date+23.58%; #1207/6202 (top 19.5%)
      ✗OshaughnessyTop 10% of eligible cross-section
    • Verdicts8% pass✓ 1✗ 12▾

      Split decision: 12 FAIL · 3 NEUTRAL · 1 PASS

      Overall verdict
      ✗GrahamFAIL (1/7)✗BuffettFAIL (1/7)✗LynchFAIL (2/6)✓PiotroskiPASS (F-Score 3)✗DremanFAIL (2/10)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (3/5)✗AckmanFAIL (2/9)✗TempletonFAIL (3/8)•SleepNEUTRAL (4/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (3/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
    • Debt & Leverage9% pass✓ 1✗ 12▾

      10 of 11 flag BRK-A's debt & leverage — Buffett, Lynch, Dreman +7 more

      Debt/Equity & Interest Coverage
      ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
      Total Debt / Equity
      ✗Lynch< 0.33
      Cash - Long-term Debt
      ✗LynchPositive preferred
      LT Debt / Total Assets Change0.00% -> 0.00%
      ✓PiotroskiDecreased YoY
      Total Debt / Shareholders' Equity
      ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
      Debt Levels
      ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
      Interest Coverage & Debt/EBITDAIC=10.4x, D/EBITDA=N/A
      ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
      Total Debt / Shareholders Equity
      ✗Ackman<= 1.0
      Negative debt-to-equity (higher means less debt)
      ✗AsnessTop 30% of eligible cross-section
      Current Assets / Current Liabilities
      ✗SchlossCurrent ratio >= 1.50x (app cutoff)
    • Valuation models20% pass✓ 2✗ 8▾

      Models split on BRK-A at $889794.00 — fair values range $236459.60–$1150771.67

      Graham fair value$722911.37
      ✗Graham-23.1% margin vs $889794.00
      Buffett fair value$1150771.67
      ✓Buffett+22.7% margin vs $889794.00
      Lynch fair value$549063.41
      ✗Lynch-62.1% margin vs $889794.00
      Dreman fair value$874375.00
      ✗Dreman-1.8% margin vs $889794.00
      Munger fair value$259321.61
      ✗Munger-243.1% margin vs $889794.00
      Pabrai fair value$415815.44
      ✗Pabrai-114.0% margin vs $889794.00
      Akre fair value$1123984.77
      ✓Akre+20.8% margin vs $889794.00
      Marks fair value$509772.00
      ✗Marks-74.5% margin vs $889794.00
      Ackman fair value$236459.60
      ✗Ackman-276.3% margin vs $889794.00
      Templeton fair value$656805.00
      ✗Templeton-35.5% margin vs $889794.00
    • Profitability27% pass✓ 11✗ 21▾

      11 of 15 flag BRK-A's profitability — Graham, Buffett, Lynch +8 more

      Net income / market capitalization+6.12%; #1390/6340 (top 21.9%)
      ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
      Positive EPS (10 years)21/28 years positive
      ✗GrahamPositive EPS every year for 10 years
      EPS Growth (3-yr avg, 10-yr window)
      ✗Graham>= 33% growth
      Net Income Positive (10+ years)27/28 years positive
      ✗BuffettPositive every year for 10+ years
      ROE (up to 5-year arithmetic mean)10.6%
      ✗Buffett> 15% arithmetic mean (app rule)
      Operating Margin (10-yr trend)14.3% (latest)
      ✗BuffettStable or rising over 10 years
      Free Cash Flow Proxy$67.0B
      ✓BuffettPositive and growing
      Earnings Variance (10-yr CoV)
      ✗BuffettCoV < 0.3
      Retained Earnings Effectiveness
      ✗Buffett$1 retained -> > $1 market value created
      Basic earnings-growth PEG (dividends excluded)1.62
      ✗Lynch< 1.0 (ideally < 0.5)
      3-5 Year EPS CAGR11.8%
      ✓Lynch15-30% (Fast Grower); > 0% to pass
      ROE10.1%
      ✗Lynch> 15%
      Net Income / Total Assets5.48%
      ✓PiotroskiROA > 0
      ROA Change YoY7.71% -> 5.48% (delta: -2.23%)
      ✗PiotroskiCurrent ROA > Prior ROA
      (CFO / Total Assets) vs ROACFO/Assets=3.76%, ROA=5.48%
      ✗PiotroskiCFO/Assets > ROA
      Pre-Tax Income / Revenue24.3%
      ✓Dreman>= 8%
      Net Income / Shareholders' Equity10.1%
      ✗Dreman> 12%
      Margin of SafetyP/E=19.1x, P/B=1.8x
      ✗PabraiP/B < 1.5 or P/E < 15
      Return on Equity13.4% (3-yr avg)
      ✗AkreROE > 20% (3-year avg)
      Discount to Intrinsic Value-1.8% (IV=$874375.00 vs Price=$889794.00)
      ✗Marks>= 20% below intrinsic value
      Positive Net Income Frequency27/28 years positive
      ✓MarksPositive net income in >= 7 of last 10 years
      Operating Income / Revenue14.3%
      ✗Ackman>= 15%
      Net Income / Shareholders Equity10.1%
      ✗Ackman>= 15%
      5-Year EPS CAGR11.8% CAGR over 5 years
      ✓Templeton> 0% (5-year EPS CAGR)
      Operating Margin Trend11.9% (2023) -> 14.3% (2025)
      ✓TempletonNon-negative operating-margin trend over 3 years
      Revenue growth vs. gross and operating margin trendrevenue up, operating margin 11.9% -> 14.3%
      ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
      Gross profit / total assets
      ✗AsnessTop 30% of eligible cross-section
      Net income / positive book equity+10.12%; #1795/5226 (top 34.3%)
      ✗AsnessTop 30% of eligible cross-section
      Negative 5-year standard deviation of ROA-0.0433; #2384/5884 (top 40.5%)
      ✗AsnessTop 30% of eligible cross-section
      3-5 Year Diluted EPS CAGR11.8% over 5 years
      ✓Neff7%-20% annualized
      Positive Diluted-EPS Years9/10 years positive
      ✓Schloss>= 70% positive over 5-10 observed years (app rule)
    • Cash Flow50% pass✓ 6✗ 6▾

      5 of 10 pass — Piotroski, Dreman, Pabrai +2 more object

      Free Cash Flow Proxy$67.0B
      ✓BuffettPositive and growing
      FCF Positive and Growing$22.8B
      ✓LynchPositive and growing
      Operating Cash Flow$46.0B
      ✓PiotroskiCFO > 0
      (CFO / Total Assets) vs ROACFO/Assets=3.76%, ROA=5.48%
      ✗PiotroskiCFO/Assets > ROA
      Price / (CFO / Shares)27.8x
      ✗Dreman< 8x
      P/E or FCF YieldP/E=19.1x, FCF Yield=2.0%
      ✗PabraiP/E < 15 or FCF Yield > 10%
      FCF Positive18/18 years FCF positive
      ✓MarksPositive FCF in majority of recent years
      (OCF - CapEx) / Market Cap1.8%
      ✗Ackman>= 4%
      Price / FCF per Share51.1x
      ✗Ackman<= 25
      Positive Operating Cash Flow frequency26/26 years positive
      ✓SleepPositive OCF in >= 70% of available years
      Operating Cash Flow - Capital Expenditures$22.8B
      ✓Neff> $0 (app proxy for a strong fundamental case)
      (Operating cash flow - capex) / market capitalization+1.81%; #2281/4519 (top 50.5%)
      ✗OshaughnessyTop 10% of eligible cross-section
    • Growth50% pass✓ 6✗ 6▾

      4 of 8 pass — Graham, Lynch, Dreman +1 more object

      EPS Growth (3-yr avg, 10-yr window)
      ✗Graham>= 33% growth
      Basic earnings-growth PEG (dividends excluded)1.62
      ✗Lynch< 1.0 (ideally < 0.5)
      3-5 Year EPS CAGR11.8%
      ✓Lynch15-30% (Fast Grower); > 0% to pass
      EPS Growth Direction
      ✗DremanPositive over recent years
      EPS CAGR
      ✗Dreman> 5% annualized
      Positive Net Income Frequency27/28 years positive
      ✓MarksPositive net income in >= 7 of last 10 years
      3yr Median Revenue Growth1.9%
      ✗Ackman>= 5%
      Positive EPS Growth Frequency2/5 years with positive EPS growth
      ✗AckmanPositive EPS growth in >= 3 of last 5 years
      5-Year EPS CAGR11.8% CAGR over 5 years
      ✓Templeton> 0% (5-year EPS CAGR)
      Revenue growth vs. gross and operating margin trendrevenue up, operating margin 11.9% -> 14.3%
      ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
      5-year Revenue CAGR8.6%
      ✓SleepCAGR > 7%
      3-5 Year Diluted EPS CAGR11.8% over 5 years
      ✓Neff7%-20% annualized

    Business & financials

    Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

    Company Profile

    Industry: Insurance
    SIC Sector: Insurance Carriers
    Size: Mega Cap($1.26T)
    Revenue: $371.4B+0.0% YoY
    Net Income: $67.0B-24.8% YoY

    Financial Snapshot

    Operating Margin14.3%
    Return on Equity9.3%
    Debt / Equity--
    Current Ratio--
    EPS (Diluted)$46563.00−24.8% 1y
    Sector-adjusted criteria: Insurer

    Insurers file unclassified balance sheets with no inventory or current accounts, so those criteria are omitted rather than failed for missing data. Return-on-invested-capital tests are omitted too: float funds the balance sheet but never appears in invested capital, and the portfolio it is invested in would be subtracted as spare cash. Debt tests are kept — an insurer’s borrowings are real leverage on top of underwriting.

    Shareholder Return

    Fiscal 2025

    Share retirement not available for this company.

    Buybacks
    —
    Dividends
    —

    What drove EPS

    A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

    FY24
    −6.8% = −7.5% + 0.8%
    FY25
    −24.8% = −24.8% + −0.0%
    Earnings Fewer shares More shares

    Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

    Company Financials

    Latest TTM and quarters alongside annual years

    TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

    The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

    MetricTTM · 2026-09-30

    2025-10-01 – 2026-09-30

    Sources · derived quarter values

    Derived from cumulative filings: revenue, net income, pre tax income, interest expense, operating cash flow, depreciation amortization, capex, buybacks.

    Q3 FY 2026

    2026-07-01 – 2026-09-30

    Sources · derived quarter values

    Derived from cumulative filings: operating cash flow, capex, buybacks.

    Q2 FY 2026

    2026-04-01 – 2026-06-30

    Sources · derived quarter values

    Derived from cumulative filings: operating cash flow, capex, buybacks.

    Q1 FY 2026

    2026-01-01 – 2026-03-31

    Sources
    FY 2025
    Sources
    • 10-K · 2026-03-02
    FY 2024
    Sources
    • 10-K · 2025-02-24
    FY 2023
    Sources
    • 10-K · 2024-02-26
    FY 2022
    Sources
    • 10-K · 2023-02-27
    FY 2021
    Sources
    • 10-K · 2022-02-28
    Market Cap$1.3Tcurrent------$1.0Test.$1.0Test.$837.5Best.$694.8Best.$709.5Best.
    Revenue$395.4B↑6%$105.6B↑11%$101.8B↑10%$93.7B↑4%$371.4B$371.4B↑2%$364.5B↑21%$302.0B↑9%$276.2B
    Operating Income--------$53.0B↓5%$55.7B↑29%$43.3B↑22%$35.5B↑10%$32.4B
    Net Income$77.1B↑14%$22.1B↓28%$25.7B↑107%$10.1B↑120%$67.0B↓25%$89.0B↓8%$96.2B↑523%-$22.8B↓125%$89.9B
    EPS (Diluted)--------$46563.00↓25%$61900.00↓7%$66412.00↑529%$-15494.00↓126%$59554.00
    Gross Margin—————————
    Operating Margin————14.3%↓5%15.0%↑26%11.9%↑1%11.8%11.7%
    ROE10.1%↑5%———9.3%↓32%13.7%↓20%17.1%↑457%-4.8%↓127%17.8%
    Total Debt------------------
    Shareholders' Equity$761.4B↑9%$761.4B↑9%$747.9B↑12%$727.2B↑11%$717.4B↑10%$649.4B↑16%$561.3B↑19%$473.4B↓6%$506.2B
    Current Ratio—————————
    Debt / Equity—————————
    Operating Cash Flow$45.1B↑14%$12.3B↓11%$11.2B↑11%$10.4B↓4%$46.0B↑50%$30.6B↓38%$49.2B↑32%$37.4B↓5%$39.4B
    Free Cash Flow$22.8B↑18%$6.8B↓18%$5.6B↑7%$5.5B↓18%$25.0B↑116%$11.6B↓61%$29.8B↑36%$21.9B↓16%$26.2B

    Score history

    Historical Score Timeline

    Industry peers

    Industry Peers

    Similar companies in Insurance

    BRK-A vs Peers — Financial Grading

    Revenue$371.4BTop 25%
    Net Income$67.0BTop 25%
    ROE9.3%Bottom 25%
    D/E—
    Op. Margin14.3%Median
    Curr. Ratio—
    CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchPiotroskiDreman
    UNITEDHEALTH GROUP INCUNH$365.1B$407.46$447.6B$12.1B12.0%0.784.2%0.793/74/72/6F-Score 63/10
    PROGRESSIVE CORP/OH/PGR$136.6B$235.78$87.7B$11.3B37.3%0.23——2/72/74/6F-Score 68/10
    MARSH & MCLENNAN COMPANIES, INC.MRSH$98.8B$207.78$27.0B$4.2B27.2%1.2823.1%1.103/73/72/6F-Score 65/10
    CHINA LIFE INSURANCE CO LTDCILJF$85.1B$3.01——————5/71/73/6F-Score 55/10
    Aon plcAON$71.8B$338.31$17.2B$3.7B39.5%1.6325.3%1.112/74/73/6F-Score 63/10
    HUMANA INCHUM$54.0B$450.00$129.7B$1.2B6.7%0.702.1%2.003/72/71/6F-Score 44/10
    SUN LIFE FINANCIAL INCSLF$40.5B$72.93$30.6B$2.6B14.5%0.33——3/73/72/6F-Score 66/10
    HARTFORD INSURANCE GROUP, INC.HIG$36.8B$137.48$28.4B$3.8B20.2%0.23——3/73/74/6F-Score 78/10